{"id":"W3031858365","doi":"10.1200/jco.2020.38.15_suppl.6531","title":"Initial analyses of a phase I/II trial of durvalumab (D) plus tremelimumab (T) and stereotactic body radiotherapy (SBRT) for oligometastatic head and neck carcinoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Adverse effect; Durvalumab; Internal medicine; Head and neck cancer; Head and neck squamous-cell carcinoma; Phases of clinical research; Nuclear medicine; Clinical trial; Radiation therapy; Cancer; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004297788,0.0009630385,0.001333867,0.000337897,0.0003054511,0.0007497969,0.0007037793,0.0009222763,0.004124415],"category_scores_gemma":[0.002267871,0.0004274884,0.00100712,0.0004260925,0.0005499964,0.0005464728,0.0003235327,0.00200686,0.0006624338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009423771,"about_ca_system_score_gemma":0.001551489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008261278,"about_ca_topic_score_gemma":0.002771407,"domain_scores_codex":[0.9988257,0.0007574611,0.0000650361,0.0001390853,0.0000767035,0.0001360426],"domain_scores_gemma":[0.9982278,0.0005002659,0.0002619249,0.0001379067,0.0001091249,0.0007630453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8801273,0.02519232,0.008310208,0.0005594951,0.001701629,0.000192331,0.0001923728,0.001859533,0.02305516,0.0002054252,0.005141556,0.0534627],"study_design_scores_gemma":[0.6080394,0.3566484,0.02250005,0.00004641455,0.001587697,0.0002430819,0.00005241396,0.001303671,0.00438631,0.0002403671,0.004923118,0.00002912134],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848627,0.002575653,0.0009025647,0.0007701423,0.0001368656,0.004351412,0.003623354,0.00008932051,0.002687912],"genre_scores_gemma":[0.9863865,0.0009000987,0.001730861,0.0007497991,0.0001122969,0.002801689,0.005125818,0.0000315069,0.002161299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004297788,"threshold_uncertainty_score":0.02272916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2800580453679873,"score_gpt":0.5396743364935574,"score_spread":0.2596162911255701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}